Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:43:02.711Z.
Calculation as of: 2026-10-06T19:43:02.711Z.
Quote observation: 2026-10-06T19:40:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80dc1f4e8b31b1f0ec5b4a1e5c631a71efe14c3ee5142d993ef0c896d26e8132
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Pyxis Oncology, Inc.
Market Cap
$127.44M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$127.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$126.43M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.82M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$123.82M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$130.16M
Operating Cash Flow Yield
0.98%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
Market Cap
$131.55M
Operating Cash Flow Yield
N/A
TTM Avg
6.01%
3Y Avg
5.49%
5Y Avg
5.49%
Market Cap
$131.16M
Operating Cash Flow Yield
21.53%
TTM Avg
12.96%
3Y Avg
8.76%
5Y Avg
8.76%
Market Cap
$121.25M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $127.44M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.51M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $126.43M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.82M | N/A | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $123.82M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $130.16M | 0.98% | 3.24% | 4.92% | 5.15% |
| LifeMD, Inc. (LFMD)vs › | $131.55M | N/A | 6.01% | 5.49% | 5.49% |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 21.53% | 12.96% | 8.76% | 8.76% |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | N/A | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $120.68M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
